209 related articles for article (PubMed ID: 33942483)
1. Development and validation of glycolysis-related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma.
Zhang XP; Chen Q; Liu Q; Wang Y; Wang F; Zhao ZM; Zhao GD; Lau WY; Gao YZ; Liu R
J Cell Mol Med; 2021 Jun; 25(12):5615-5627. PubMed ID: 33942483
[TBL] [Abstract][Full Text] [Related]
2. Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma.
Okada Y; Nishiwada S; Yamamura K; Sho M; Baba H; Takayama T; Goel A
Eur J Cancer; 2021 Mar; 146():125-134. PubMed ID: 33607476
[TBL] [Abstract][Full Text] [Related]
3. A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma.
Sun X; Song H; Sun X; Liao C; Wang G; Xu Y; Li L; Han Y; Xu C; Wang W; Cai S; Liang H; Yu H
Cancer Invest; 2024 Mar; 42(3):226-242. PubMed ID: 38616304
[TBL] [Abstract][Full Text] [Related]
4. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma.
Li F; Si W; Xia L; Yin D; Wei T; Tao M; Cui X; Yang J; Hong T; Wei R
Mol Cancer; 2024 May; 23(1):90. PubMed ID: 38711083
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
George B; Kudryashova O; Kravets A; Thalji S; Malarkannan S; Kurzrock R; Chernyavskaya E; Gusakova M; Kravchenko D; Tychinin D; Savin E; Alekseeva L; Butusova A; Bagaev A; Shin N; Brown JH; Sethi I; Wang D; Taylor B; McFall T; Kamgar M; Hall WA; Erickson B; Christians KK; Evans DB; Tsai S
Gastroenterology; 2024 May; 166(5):859-871.e3. PubMed ID: 38280684
[TBL] [Abstract][Full Text] [Related]
6. Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.
Tuerhong A; Xu J; Shi S; Tan Z; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Liang C
Cell Mol Life Sci; 2021 Jul; 78(14):5505-5526. PubMed ID: 34131808
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer.
Liu X; Ren B; Fang Y; Ren J; Wang X; Gu M; Zhou F; Xiao R; Luo X; You L; Zhao Y
J Transl Med; 2024 Apr; 22(1):393. PubMed ID: 38685045
[TBL] [Abstract][Full Text] [Related]
8. Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma.
Jiang L; Qin J; Dai Y; Zhao S; Zhan Q; Cui P; Ren L; Wang X; Zhang R; Gao C; Zhou Y; Cai S; Wang G; Xie W; Tang X; Shi M; Ma F; Liu J; Wang T; Wang C; Svrcek M; Bardier-Dupas A; Emile JF; de Mestier L; Bachet JB; Nicolle R; Cros J; Laurent-Puig P; Wei M; Song B; Jing W; Guo S; Zheng K; Jiang H; Wang H; Deng X; Chen H; Tian Q; Wang S; Shi S; Jin G; Yin T; Fang H; Chen S; Shen B
Nat Med; 2024 Mar; 30(3):749-761. PubMed ID: 38287168
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4.
Camolotto SA; Belova VK; Torre-Healy L; Vahrenkamp JM; Berrett KC; Conway H; Shea J; Stubben C; Moffitt R; Gertz J; Snyder EL
Gut; 2021 May; 70(5):900-914. PubMed ID: 32826305
[TBL] [Abstract][Full Text] [Related]
10. Expression landscape of cancer-FOXP3 and its prognostic value in pancreatic adenocarcinoma.
Gong R; Wang J; Xing Y; Wang J; Chen X; Lei K; Yu Q; Zhao C; Li S; Zhang Y; Wang H; Ren H
Cancer Lett; 2024 May; 590():216838. PubMed ID: 38561039
[TBL] [Abstract][Full Text] [Related]
11. Prognostic effect of CD73 in pancreatic ductal adenocarcinoma for disease-free survival after radical surgery.
Qin D; Wei R; Huang K; Wang R; Ding H; Yao Z; Xi P; Li S
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7805-7817. PubMed ID: 37032378
[TBL] [Abstract][Full Text] [Related]
12. Topographic analysis of pancreatic cancer by TMA and digital spatial profiling reveals biological complexity with potential therapeutic implications.
Bingham V; Harewood L; McQuaid S; Craig SG; Revolta JF; Kim CS; Srivastava S; Quezada-Marín J; Humphries MP; Salto-Tellez M
Sci Rep; 2024 May; 14(1):11361. PubMed ID: 38762572
[TBL] [Abstract][Full Text] [Related]
13. Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling.
Wen S; Zhan B; Feng J; Hu W; Lin X; Bai J; Huang H
BMC Cancer; 2017 Nov; 17(1):708. PubMed ID: 29096620
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression.
Ogunleye AO; Nimmakayala RK; Batra SK; Ponnusamy MP
Stem Cells; 2023 May; 41(5):417-430. PubMed ID: 36869789
[TBL] [Abstract][Full Text] [Related]
15. Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.
Swierczynski J; Hebanowska A; Sledzinski T
World J Gastroenterol; 2014 Mar; 20(9):2279-303. PubMed ID: 24605027
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance.
Kaoutari AE; Fraunhoffer NA; Hoare O; Teyssedou C; Soubeyran P; Gayet O; Roques J; Lomberk G; Urrutia R; Dusetti N; Iovanna J
EBioMedicine; 2021 Apr; 66():103332. PubMed ID: 33862584
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of a novel immunological model to predict prognosis in pancreatic ductal adenocarcinoma.
Liu J; He M
Int Immunopharmacol; 2024 May; 134():112266. PubMed ID: 38761784
[TBL] [Abstract][Full Text] [Related]
18. BEYOND TRADITIONAL TOOLS: EXPLORING CONVOLUTIONAL NEURAL NETWORKS AS INNOVATIVE PROGNOSTIC MODELS IN PANCREATIC DUCTAL ADENOCARCINOMA.
Ahmed HS
Arq Gastroenterol; 2024; 61():e23107. PubMed ID: 38511794
[TBL] [Abstract][Full Text] [Related]
19. Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis prediction.
Teng T; Shi H; Fan Y; Guo P; Zhang J; Qiu X; Feng J; Huang H
Sci Rep; 2024 Mar; 14(1):6938. PubMed ID: 38521793
[TBL] [Abstract][Full Text] [Related]
20. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets.
Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
